Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome
Yıl: 2021 Cilt: 30 Sayı: 1 Sayfa Aralığı: 67 - 68 Metin Dili: İngilizce DOI: 10.4274/mirt.galenos.2021.58561 İndeks Tarihi: 19-05-2021
Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Alipour Z, Armin A, Mohamadi S, Tabib SM, Azizmohammadi Z, Gholamrezanezhad A, Assadi M. Hepatopulmonary Syndrome with Right-to-left Shunt in Cirrhotic Patients Using Macro-Aggregated Albumin Lung Perfusion Scan: Comparison with Contrast Echocardiography and Association with Clinical Data. Mol Imaging Radionucl Ther 2020;29:1-6.
- 2. Meristoudis G, Keramida G, Ilias I. Lung Perfusion Imaging with Technetium-99m Macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. Mol Imaging Radionucl Ther 2020;29:143-144.
- 3. Ito K, Kurihara K, Ishibashi A, Morooka M, Mitsumoto T, Minamimoto R, Kubota K. Cut-off value for normal versus abnormal right-to-left shunt percentages using (99m)Tc-macroaggregated albumin. Nucl Med Commun 2011;32:936-940.
- 4. Zhao H, Tsauo J, Zhang XW, Ma HY, Weng NN, Tang GS, Li X. Technetium-99m-labeled macroaggregated albumin lung perfusion scan for diagnosis of hepatopulmonary syndrome: A prospective study comparing brain uptake and whole-body uptake. World J Gastroenterol 2020;26:1088-1097.
- 5. Krowka MJ. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology 1997;25:1282-1284.
- 6. Teuber G, Teupe C, Dietrich CF, Caspary WF, Buhl R, Zeuzem S. Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis. Eur J Intern Med 2002;13:311-318.
| APA | Assadi M (2021). Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. , 67 - 68. 10.4274/mirt.galenos.2021.58561 |
| Chicago | Assadi Majid Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. (2021): 67 - 68. 10.4274/mirt.galenos.2021.58561 |
| MLA | Assadi Majid Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. , 2021, ss.67 - 68. 10.4274/mirt.galenos.2021.58561 |
| AMA | Assadi M Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. . 2021; 67 - 68. 10.4274/mirt.galenos.2021.58561 |
| Vancouver | Assadi M Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. . 2021; 67 - 68. 10.4274/mirt.galenos.2021.58561 |
| IEEE | Assadi M "Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome." , ss.67 - 68, 2021. 10.4274/mirt.galenos.2021.58561 |
| ISNAD | Assadi, Majid. "Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome". (2021), 67-68. https://doi.org/10.4274/mirt.galenos.2021.58561 |
| APA | Assadi M (2021). Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. Molecular Imaging and Radionuclide Therapy, 30(1), 67 - 68. 10.4274/mirt.galenos.2021.58561 |
| Chicago | Assadi Majid Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. Molecular Imaging and Radionuclide Therapy 30, no.1 (2021): 67 - 68. 10.4274/mirt.galenos.2021.58561 |
| MLA | Assadi Majid Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. Molecular Imaging and Radionuclide Therapy, vol.30, no.1, 2021, ss.67 - 68. 10.4274/mirt.galenos.2021.58561 |
| AMA | Assadi M Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. Molecular Imaging and Radionuclide Therapy. 2021; 30(1): 67 - 68. 10.4274/mirt.galenos.2021.58561 |
| Vancouver | Assadi M Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome. Molecular Imaging and Radionuclide Therapy. 2021; 30(1): 67 - 68. 10.4274/mirt.galenos.2021.58561 |
| IEEE | Assadi M "Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome." Molecular Imaging and Radionuclide Therapy, 30, ss.67 - 68, 2021. 10.4274/mirt.galenos.2021.58561 |
| ISNAD | Assadi, Majid. "Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome". Molecular Imaging and Radionuclide Therapy 30/1 (2021), 67-68. https://doi.org/10.4274/mirt.galenos.2021.58561 |
